Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-02-2009 | Original Article

Assessment of various strategies for ¹⁸F-FET PET-guided delineation of target volumes in high-grade glioma patients

Authors: Hansjörg Vees, Srinivasan Senthamizhchelvan, Raymond Miralbell, Damien C. Weber, Osman Ratib, Habib Zaidi

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2009

Abstract

Purpose

The purpose of the study is to assess the contribution of ¹⁸F-fluoro-ethyl-tyrosine (¹⁸F-FET) positron emission tomography (PET) in the delineation of gross tumor volume (GTV) in patients with high-grade gliomas compared with magnetic resonance imaging (MRI) alone.

Materials and methods

The study population consisted of 18 patients with high-grade gliomas. Seven image segmentation techniques were used to delineate ¹⁸F-FET PET GTVs, and the results were compared to the manual MRI-derived GTV (GTV_MRI). PET image segmentation techniques included manual delineation of contours (GTV_man), a 2.5 standardized uptake value (SUV) cutoff (GTV_2.5), a fixed threshold of 40% and 50% of the maximum signal intensity (GTV_40% and GTV_50%), signal-to-background ratio (SBR)-based adaptive thresholding (GTV_SBR), gradient find (GTV_GF), and region growing (GTV_RG). Overlap analysis was also conducted to assess geographic mismatch between the GTVs delineated using the different techniques.

Results

Contours defined using GTV_2.5 failed to provide successful delineation technically in three patients (18% of cases) as SUV_max< 2.5 and clinically in 14 patients (78% of cases). Overall, the majority of GTVs defined on PET-based techniques were usually smaller than GTV_MRI (67% of cases). Yet, PET detected frequently tumors that are not visible on MRI and added substantially tumor extension outside the GTV_MRI in six patients (33% of cases).

Conclusions

The selection of the most appropriate ¹⁸F-FET PET-based segmentation algorithm is crucial, since it impacts both the volume and shape of the resulting GTV. The 2.5 SUV isocontour and GF segmentation techniques performed poorly and should not be used for GTV delineation. With adequate setting, the SBR-based PET technique may add considerably to conventional MRI-guided GTV delineation.

Omuro AM, Delattre JY. Editorial: what is new in the treatment of gliomas? Curr Opin Neurol 2007;20:704–7.PubMedCrossRef

DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114–23.PubMedCrossRef

Popperl G, Tatsch K, Kreth FW, Tonn JC. Brain tumors. Recent Results Cancer Res 2008;170:33–47.PubMed

Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988;38:1371–4.PubMed

Rachinger W, Goetz C, Popperl G, et al. Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 2005;57:505–11.PubMedCrossRef

Pauleit D, Floeth F, Hamacher K, et al. O-(2-[18F]fluoroethyl)-l-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005;128:678–87.PubMedCrossRef

Chen W. Clinical applications of PET in brain tumors. J Nucl Med 2007;48:1468–81.PubMedCrossRef

Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432–45.PubMed

Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-l-tyrosine in vitro and in vivo. J Nucl Med 1999;40:1367–73.PubMed

10.

Spaeth N, Wyss MT, Weber B, et al. Uptake of 18F-fluorocholine, 18F-fluoroethyl-l-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med 2004;45:1931–8.PubMed

11.

Popperl G, Goldbrunner R, Gildehaus FJ, et al. O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging 2005;32:1018–25.PubMedCrossRef

12.

Mehrkens JH, Popperl G, Rachinger W, et al. The positive predictive value of O-(2-[(18)F]fluoroethyl)-l-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment. J Neurooncol 2008;88:27–35.PubMedCrossRef

13.

Pauleit D, Floeth F, Tellmann L, et al. Comparison of O-(2–18F-fluoroethyl)-l-tyrosine PET and 3-123I-iodo-alpha-methyl-l-tyrosine SPECT in brain tumors. J Nucl Med 2004;45:374–81.PubMed

14.

Gregoire V, Haustermans K, Geets X, Roels S, Lonneux M. PET-based treatment planning in radiotherapy: A new standard? J Nucl Med 2007;48:68S–77S.PubMed

15.

Boudraa A, Zaidi H. Image segmentation techniques in nuclear medicine imaging. In: Zaidi H, editor. Quantitative analysis of nuclear medicine images. New York: Springer; 2006. p. 308–57.CrossRef

16.

van Baardwijk A, Baumert BG, Bosmans G, et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev 2006;32:245–60.PubMedCrossRef

17.

Erdi Y, Mawlawi O, Larson S, et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. radioimmunodetection and radioimmunotherapy of cancer, Princeton, New Yersey, 1997:2505–2509.

18.

Daisne JF, Sibomana M, Bol A, Doumont T, Lonneux M, Gregoire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 2003;69:247–50.PubMedCrossRef

19.

Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003;57:853–63.PubMed

20.

Yaremko B, Riauka T, Robinson D, et al. Thresholding in PET images of static and moving targets. Phys Med Biol 2005;50:5969–82.PubMedCrossRef

21.

Nestle U, Kremp S, Schaefer-Schuler A, et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med 2005;46:1342–8.PubMed

22.

Drever L, Roa W, McEwan A, Robinson D. Iterative threshold segmentation for PET target volume delineation. Med Phys 2007;34:1253–65.PubMedCrossRef

23.

Schinagl DA, Vogel WV, Hoffmann AL, van Dalen JA, Oyen WJ, Kaanders JH. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:1282–9.PubMed

24.

Hatt M, Lamare F, Boussion N, et al. Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET. Phys Med Biol 2007;52:3467–91.PubMedCrossRef

25.

Montgomery D, Amira A, Zaidi H. Fully automated segmentation of oncological PET volumes using a combined multiscale and statistical model. Med Phys 2007;34:722–36.PubMedCrossRef

26.

Hong R, Halama J, Bova D, Sethi A, Emami B. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning. Int J Radiat Oncol Biol Phys 2007;67:720–6.PubMed

27.

Jannin P, Fitzpatrick JM, Hawkes DJ, Pennec X, Shahidi R, Vannier MW. Validation of medical image processing in image-guided therapy. IEEE Trans Med Imaging 2002;21:1445–9.PubMedCrossRef

28.

Pauleit D, Floeth F, Herzog H, et al. Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosine. Eur J Nucl Med Mol Imaging 2003;30:519–24.PubMed

29.

Graves EE, Quon A, Loo BW Jr. RT_Image: an open-source tool for investigating PET in radiation oncology. Technol Cancer Res Treat 2007;6:111–21.PubMed

30.

Jentzen W, Freudenberg L, Eising EG, Heinze M, Brandau W, Bockisch A. Segmentation of PET volumes by iterative image thresholding. J Nucl Med 2007;48:108–14.PubMed

31.

Basu S, Zaidi H, Houseni M, et al. Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: Implications for normal variation, aging and diseased states. Sem Nucl Med 2007;37:223–39.CrossRef

32.

Plotkin M, Gneveckow U, Meier-Hauff K, et al. 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. Int J Hyperthermia 2006;22:319–25.PubMedCrossRef

33.

Floeth FW, Pauleit D, Sabel M, et al. 18F-FET PET differentiation of ring-enhancing brain lesions. J Nucl Med 2006;47:776–82.PubMed

34.

Langen KJ, Floeth FW, Stoffels G, Hamacher K, Coenen HH, Pauleit D. Improved diagnostics of cerebral gliomas using FET PET. Z Med Phys 2007;17:237–41.PubMed

35.

Mosskin M, von Holst H, Bergstrom M, et al. Positron emission tomography with 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol 1987;28:673–81.PubMedCrossRef

36.

Grosu AL, Weber WA, Franz M, et al. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:511–9.PubMed

37.

Grosu AL, Weber WA, Riedel E, et al. l-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:64–74.PubMed

38.

Mahasittiwat P, Mizoe JE, Hasegawa A, et al. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:515–22.PubMed

39.

Daisne JF, Dupers T, Weygand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004;233:93–100.PubMedCrossRef

40.

Weber WA, Wester HJ, Grosu AL, et al. O-(2-[18F]fluoroethyl)-l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000;27:542–9.PubMedCrossRef

41.

Pirzkall A, Li X, Oh J, et al. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 2004;59:126–37.PubMed

42.

Zhang YJ. A survey on evaluation methods for image segmentation. Patt Recogn Letters 1996;29:1335–46.CrossRef

Title: Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients
Authors: Hansjörg Vees
Srinivasan Senthamizhchelvan
Raymond Miralbell
Damien C. Weber
Osman Ratib
Habib Zaidi
Publication date: 01-02-2009
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2009
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-008-0943-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Assessment of various strategies for ¹⁸F-FET PET-guided delineation of target volumes in high-grade glioma patients

Abstract

Purpose

Materials and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2009

Respiratory and cardiac motion correction with 4D PET imaging: shooting at moving targets

Reply to: False-negative thyroglobulin measurement in recurrent/metastatic thyroid carcinomas

[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model

Multimodality molecular imaging — from target description to clinical studies

Preoperative cerebrovascular reactivity to acetazolamide measured by brain perfusion SPECT predicts development of cerebral ischemic lesions caused by microemboli during carotid endarterectomy

A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma